Per Westermark

31.3k citations
404 papers · 26k · 8 hit papers · h-index 84

Impact in

  • Physiology top 0.1%
    • Alzheimer's disease research and treatments
    • Amyloidosis: Diagnosis, Treatment, Outcomes
    • Prion Diseases and Protein Misfolding
    • Protein Structure and Dynamics
    • Protein purification and stability

Papers in

    • Amyloidosis: Diagnosis, Treatment, Outcomes 260
    • Prion Diseases and Protein Misfolding 15
    • Pancreatic function and diabetes 100

Per Westermark

395 papers receiving 24.7k citations

Per Westermark's Hit Papers

Amyloid nomenclature 2022: update, novel proteins, and recommendations by the International Society of Amyloidosis (ISA) Nomenclature Committee 2022 · 228 citations
2280+13+26Years since publication250500750

Peers

Per Westermark
Comparison fields: 5 of 149
  • Physiology 5.9k
  • Molecular Biology 14.4k
  • Surgery 5.8k
  • Endocrine and Autonomic Systems 358
  • Endocrinology, Diabetes and Metabolism 911
Replace Gunilla Torstensdotter Westermark with:
Gunilla Torstensdotter Westermark Sweden
Alan L. Schwartz United States
Dudley K. Strickland United States
Søren K. Moestrup Denmark
Frances M. Platt United Kingdom
Shaun R. Coughlin United States
Nicos Anthony Nicola Australia
Angela Santoni Italy
Dietmar Vestweber Germany
David M. Neville United States
Per Westermark relative to Gunilla Torstensdotter Westermark Sweden Gunilla Torstensdotter Westermark's profile →
Citations per field
00.5×2×3×3.7×
Gunilla Torstensdotter Westermark · 1×
Citations per year

Countries citing papers authored by Per Westermark

Since Specialization
Citations

This map shows the geographic impact of Per Westermark's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Per Westermark with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Per Westermark more than expected).

Fields of papers citing papers by Per Westermark

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Per Westermark. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Per Westermark. The network helps show where Per Westermark may publish in the future.

Co-authors

The 25 scholars most cited alongside Per Westermark, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Per Westermark Line = papers co-authored together Per Westermark links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 404 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Islet Amyloid Polypeptide, Islet Amyloid, and Diabetes Mellitus
Hit paper breakdown →
2011871
2
Amyloid fibrils in human insulinoma and islets of Langerhans of the diabetic cat are derived from a neuropeptide-like protein also present in normal islet cells.
Hit paper breakdown →
1987863
3
Islet amyloid polypeptide: pinpointing amino acid residues linked to amyloid fibril formation.
Hit paper breakdown →
1990720
4 1990593
5
Islet Amyloid: A Critical Entity in the Pathogenesis of Type 2 Diabetes
Hit paper breakdown →
2004482
6 2016474
7
Amyloid nomenclature 2018: recommendations by the International Society of Amyloidosis (ISA) nomenclature committee
Hit paper breakdown →
2018451
8
A novel peptide in the calcitonin gene related peptide family as an amyloid fibril protein in the endocrine pancreas
Hit paper breakdown →
1986446
9 2014420
10 1983391
11 2004363
12 1989326
13 2020306
14 2011282
15 2010281
16 2007273
17 1988268
18 2005267
19 2005258
20 1999254

About Per Westermark

Per Westermark is a scholar working on Molecular Biology, Surgery, Physiology, Endocrinology, Diabetes and Metabolism and Dermatology, having authored 404 papers that have together received 26k indexed citations. Recurring topics across this work include Amyloidosis: Diagnosis, Treatment, Outcomes (260 papers), Pancreatic function and diabetes (100 papers), Alzheimer's disease research and treatments (33 papers), Prion Diseases and Protein Misfolding (15 papers), Diabetes Treatment and Management (6 papers), Neuroendocrine Tumor Research Advances (5 papers), Neuropeptides and Animal Physiology (5 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). The work is most often cited by research in Physiology (5.9k citations), Molecular Biology (14.4k citations), Surgery (5.8k citations), Endocrine and Autonomic Systems (358 citations) and Endocrinology, Diabetes and Metabolism (911 citations). Per Westermark has collaborated with scholars based in Sweden, United States and Norway. Frequent co-authors include Gunilla Torstensdotter Westermark, Knut Sletten, Erik Wilander, Kenneth H. Johnson, Giampaolo Merlini, Timothy D. O’Brien, Gibbons G. Cornwell, Maria João Saraiva, Joel N. Buxbaum and Ulla Engström. Their work appears in journals such as Amyloid, Biochemical and Biophysical Research Communications, Scandinavian Journal of Immunology, Diabetologia and Proceedings of the National Academy of Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact